Conjunctivitis in COVID-19 patients: frequency and clinical presentation
Noemí Güemes-Villahoz(Hospital Clínico San Carlos), María Herrera de la Muela(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Barbara Burgos‐Blasco(University of British Columbia), J.M. Martínez-de-la-Casa(Universidad Complutense de Madrid), F. Sáenz-Francés(Universidad Complutense de Madrid), J.M. Benítez-del-Castillo(Universidad Complutense de Madrid), Pedro Arriola‐Villalobos(Universidad Complutense de Madrid)
Graefe s Archive for Clinical and Experimental Ophthalmology
August 29, 2020
Cited by 86
Related Papers
Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?
|Journal of Medical Virology|2020|81
Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea
|Acta Ophthalmologica|2021|68
Tear and aqueous humour cytokine profile in primary open‐angle glaucoma
|Acta Ophthalmologica|2020|62
Topical insulin for refractory persistent corneal epithelial defects
|European Journal of Ophthalmology|2020|59
Optic nerve and macular optical coherence tomography in recovered COVID-19 patients
|European Journal of Ophthalmology|2021|51